medroxyprogesterone acetate has been researched along with Dementia in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.76) | 18.7374 |
| 1990's | 1 (4.76) | 18.2507 |
| 2000's | 13 (61.90) | 29.6817 |
| 2010's | 6 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, S | 1 |
| Kantarci, K; Maki, PM | 1 |
| Brinton, RD; Craft, S; Espeland, MA; Hugenschmidt, C; Jackson, RD; Johnson, KC; Manson, JE; Padula, CB; Resnick, SM; Vaughan, L; Weitlauf, J; Yaffe, K | 1 |
| Bushnell, CA; Espeland, MA; Jaramillo, SA; Kuller, LH; Maldjian, JA; Margolis, KL; Melhem, ER; Mysiw, WJ; Resnick, SM; Tindle, HA | 1 |
| King, J; Morrison, JH; Naftolin, F | 1 |
| Brunner, RL; Coker, LH; Espeland, MA; Granek, I; Hogan, PE; Legault, C; Rapp, SR; Resnick, SM | 1 |
| Henderson, VW; Maki, PM | 1 |
| Assaf, AR; Hendrix, SL; Jackson, RD; Jones, BN; Kotchen, JM; Legault, C; Ockene, JK; Rapp, SR; Shumaker, SA; Thal, L; Wactawski-Wende, J; Wallace, RB; Wassertheil-Smoller, S | 1 |
| Wooltorton, E | 1 |
| Brinton, RD; Nilsen, J | 1 |
| Yoon, BK | 1 |
| Culhane, NS | 1 |
| Wickelgren, I | 1 |
| Coker, LH; Fillit, H; Hendrix, SL; Kuller, L; Lane, DS; Legault, C; Lewis, CE; Masaki, K; Rapp, SR; Shumaker, SA; Stefanick, ML; Thal, L | 1 |
| Brunner, R; Dailey, M; Espeland, MA; Freeman, R; Hays, J; Hogan, PE; Hsia, J; Manson, JE; Margolis, KL; Rapp, SR; Sherwin, BB; Shumaker, SA; Wallace, R | 1 |
| Schneider, LS | 1 |
| Stewart, JT | 1 |
| Holroyd, S; Light, SA | 1 |
| Amadeo, M | 1 |
| Cooper, AJ | 1 |
1 review(s) available for medroxyprogesterone acetate and Dementia
| Article | Year |
|---|---|
Hormone therapy, dementia, and cognition: the Women's Health Initiative 10 years on.
Topics: Aged; Aging; Alzheimer Disease; Cognition; Cognition Disorders; Dementia; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Memory; Middle Aged; Postmenopause; Randomized Controlled Trials as Topic; Women's Health | 2012 |
6 trial(s) available for medroxyprogesterone acetate and Dementia
| Article | Year |
|---|---|
Impact of Type 2 Diabetes and Postmenopausal Hormone Therapy on Incidence of Cognitive Impairment in Older Women.
Topics: Aged; Aged, 80 and over; Brain; Cognition; Cognition Disorders; Dementia; Diabetes Mellitus, Type 2; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Glucose; Humans; Incidence; Medroxyprogesterone Acetate; Postmenopause; Randomized Controlled Trials as Topic; Risk | 2015 |
Brain volumes, cognitive impairment, and conjugated equine estrogens.
Topics: Age Factors; Aged; Aged, 80 and over; Aging; Analysis of Variance; Brain; Cognition Disorders; Dementia; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Incidence; Kaplan-Meier Estimate; Logistic Models; Magnetic Resonance Imaging; Medroxyprogesterone Acetate; Neuropsychological Tests; Organ Size; Postmenopause; Prognosis; Risk Assessment; Statistics, Nonparametric | 2009 |
Long-term effects of conjugated equine estrogen therapies on domain-specific cognitive function: results from the Women's Health Initiative study of cognitive aging extension.
Topics: Aged; Aged, 80 and over; Aging; Cognition; Dementia; Drug Administration Schedule; Drug Combinations; Early Termination of Clinical Trials; Estrogens; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Psychological Tests | 2010 |
Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
Topics: Aged; Cognition; Cognition Disorders; Dementia; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Neuropsychological Tests; Postmenopause; Progesterone Congeners; Proportional Hazards Models; Risk | 2003 |
Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.
Topics: Aged; Cognition Disorders; Dementia; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Incidence; Medroxyprogesterone Acetate; Postmenopause; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk | 2004 |
Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study.
Topics: Aged; Cognition Disorders; Dementia; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Postmenopause; Randomized Controlled Trials as Topic; Risk | 2004 |
14 other study(ies) available for medroxyprogesterone acetate and Dementia
| Article | Year |
|---|---|
IMS updates its recommendations on the use of HRT.
Topics: Cognition; Cognition Disorders; Dementia; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Progesterone Congeners | 2013 |
Past hormone therapy in older women: does the brain recover from adverse effects?
Topics: Age Factors; Aged; Animals; Brain; Dementia; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Horses; Humans; Medroxyprogesterone Acetate | 2014 |
Post hoc magnetic resonance imaging cannot justify the conclusions of WHIMS.
Topics: Aged; Aged, 80 and over; Brain; Cognition Disorders; Dementia; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Magnetic Resonance Imaging; Medroxyprogesterone Acetate | 2010 |
Combination hormone replacement therapy and dementia.
Topics: Aged; Dementia; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Postmenopause; Progesterone Congeners | 2003 |
Effects of estrogen plus progestin on risk of dementia.
Topics: Aged; Alzheimer Disease; Dementia; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Progesterone Congeners; Risk | 2003 |
Effects of estrogen plus progestin on risk of dementia.
Topics: Aged; Alzheimer Disease; Cognition; Dementia; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Progesterone Congeners; Risk | 2003 |
Estrogen plus progestin may increase incidence of dementia.
Topics: Aged; Cognition Disorders; Dementia; Double-Blind Method; Drug Combinations; Estrogen Replacement Therapy; Estrogens; Female; Humans; Incidence; Medroxyprogesterone Acetate; Postmenopause; Randomized Controlled Trials as Topic; Reproducibility of Results; United States | 2003 |
Estrogen research. Brain researchers try to salvage estrogen treatments.
Topics: Age Factors; Aged; Animals; Brain; Cognition; Dementia; Drug Combinations; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Neurons; Neuroprotective Agents; Patient Selection; Progesterone; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Time Factors | 2003 |
Estrogen and dementia: insights from the Women's Health Initiative Memory Study.
Topics: Aged; Cognition Disorders; Dementia; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Postmenopause; Randomized Controlled Trials as Topic; Risk | 2004 |
Post-menopausal hormone replacement therapy (cont'd): risk-benefit balance in the hot seat.
Topics: Breast Neoplasms; Coronary Disease; Dementia; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Europe; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Randomized Controlled Trials as Topic; Risk Assessment; Stroke; Thromboembolism; Time Factors; United States; Women's Health | 2004 |
Optimizing antilibidinal treatment with medroxyprogesterone acetate.
Topics: Aged; Contraceptive Agents, Male; Dementia; Humans; Libido; Male; Medroxyprogesterone Acetate; Paraphilic Disorders; Testosterone | 2005 |
The use of medroxyprogesterone acetate for the treatment of sexually inappropriate behaviour in patients with dementia.
Topics: Aged; Dementia; Humans; Male; Medroxyprogesterone Acetate; Sexual Behavior | 2006 |
Antiandrogen treatment of aggressivity in men suffering from dementia.
Topics: Aged; Aged, 80 and over; Aggression; Alzheimer Disease; Androgen Antagonists; Dementia; Humans; Leuprolide; Male; Medroxyprogesterone Acetate; Psychomotor Agitation; Social Behavior | 1996 |
Medroxyprogesterone acetate (MPA) treatment of sexual acting out in men suffering from dementia.
Topics: Acting Out; Aged; Aged, 80 and over; Compulsive Behavior; Dementia; Follow-Up Studies; Humans; Luteinizing Hormone; Male; Masturbation; Medroxyprogesterone; Medroxyprogesterone Acetate; Outcome and Process Assessment, Health Care; Prolactin; Sexual Behavior; Testosterone | 1987 |